Literature DB >> 30989321

CD8+ T cell exhaustion.

Makoto Kurachi1.   

Abstract

CD8+ T cells are important for the protective immunity against intracellular pathogens and tumor. In the case of chronic infection or cancer, CD8+ T cells are exposed to persistent antigen and/or inflammatory signals. This excessive amount of signals often leads CD8+ T cells to gradual deterioration of T cell function, a state called "exhaustion." Exhausted T cells are characterized by progressive loss of effector functions (cytokine production and killing function), expression of multiple inhibitory receptors (such as PD-1 and LAG3), dysregulated metabolism, poor memory recall response, and homeostatic proliferation. These altered functions are closely related with altered transcriptional program and epigenetic landscape that clearly distinguish exhausted T cells from normal effector and memory T cells. T cell exhaustion is often associated with inefficient control of persisting infections and cancers, but re-invigoration of exhausted T cells with inhibitory receptor blockade can promote improved immunity and disease outcome. Accumulating evidences support the therapeutic potential of targeting exhausted T cells. However, exhausted T cells comprise heterogenous cell population with distinct responsiveness to intervention. Understanding molecular mechanism of T cell exhaustion is essential to establish rational immunotherapeutic interventions.

Entities:  

Keywords:  CD8 T cell; Cancer immunotherapy; Chronic infection; Exhaustion; Inhibitory receptor

Year:  2019        PMID: 30989321     DOI: 10.1007/s00281-019-00744-5

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  112 in total

1.  NFATc1 regulates PD-1 expression upon T cell activation.

Authors:  Kenneth J Oestreich; Hyesuk Yoon; Rafi Ahmed; Jeremy M Boss
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 2.  T cell exhaustion.

Authors:  E John Wherry
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

3.  Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.

Authors:  E John Wherry; Joseph N Blattman; Kaja Murali-Krishna; Robbert van der Most; Rafi Ahmed
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

4.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

5.  PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A.

Authors:  Nikolaos Patsoukis; Duygu Sari; Vassiliki A Boussiotis
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

6.  Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells.

Authors:  Joseph F Grosso; Monica V Goldberg; Derese Getnet; Tullia C Bruno; Hung-Rong Yen; Kristin J Pyle; Edward Hipkiss; Dario A A Vignali; Drew M Pardoll; Charles G Drake
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

Review 7.  Networking at the level of host immunity: immune cell interactions during persistent viral infections.

Authors:  Cherie T Ng; Laura M Snell; David G Brooks; Michael B A Oldstone
Journal:  Cell Host Microbe       Date:  2013-06-12       Impact factor: 21.023

8.  Natural killer cells act as rheostats modulating antiviral T cells.

Authors:  Stephen N Waggoner; Markus Cornberg; Liisa K Selin; Raymond M Welsh
Journal:  Nature       Date:  2011-11-20       Impact factor: 49.962

9.  Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection.

Authors:  Pablo Penaloza-MacMaster; Alice O Kamphorst; Andreas Wieland; Koichi Araki; Smita S Iyer; Erin E West; Leigh O'Mara; Shu Yang; Bogumila T Konieczny; Arlene H Sharpe; Gordon J Freeman; Alexander Y Rudensky; Rafi Ahmed
Journal:  J Exp Med       Date:  2014-08-11       Impact factor: 14.307

10.  Macrophage and T cell produced IL-10 promotes viral chronicity.

Authors:  Kirsten Richter; Guillaume Perriard; Rayk Behrendt; Reto A Schwendener; Veronika Sexl; Robert Dunn; Masahito Kamanaka; Richard A Flavell; Axel Roers; Annette Oxenius
Journal:  PLoS Pathog       Date:  2013-11-07       Impact factor: 6.823

View more
  43 in total

1.  Pathogenicity of acquired immunity in human diseases.

Authors:  Kiyoshi Hirahara
Journal:  Semin Immunopathol       Date:  2019-05-07       Impact factor: 9.623

2.  Characterization of senescence biomarkers in rheumatoid arthritis: relevance to disease progression.

Authors:  Laura E Petersen; Jaqueline B Schuch; Lucas A de Azeredo; Talita S A Baptista; Julia G Motta; Aline D do Prado; Moisés Evandro Bauer
Journal:  Clin Rheumatol       Date:  2019-06-11       Impact factor: 2.980

3.  TIGIT promotes CD8+T cells exhaustion and predicts poor prognosis of colorectal cancer.

Authors:  Rongpu Liang; Xudong Zhu; Tianyun Lan; Dongbing Ding; Zongheng Zheng; Tufeng Chen; Yong Huang; Jianpei Liu; Xiaofeng Yang; Jun Shao; Hongbo Wei; Bo Wei
Journal:  Cancer Immunol Immunother       Date:  2021-02-26       Impact factor: 6.968

Review 4.  Genomics-Guided Immunotherapy for Precision Medicine in Cancer.

Authors:  Shradha Mukherjee
Journal:  Cancer Biother Radiopharm       Date:  2019-07-16       Impact factor: 3.099

Review 5.  A Darwinian perspective on tumor immune evasion.

Authors:  Julieann Puleo; Kornelia Polyak
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-12-18       Impact factor: 10.680

6.  Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer.

Authors:  Aislyn Schalck; Donastas Sakellariou-Thompson; Michael P Kim; Nicholas E Navin; Chantale Bernatchez; Marie-Andrée Forget; Emi Sei; Tara G Hughes; Alexandre Reuben; Shanshan Bai; Min Hu; Tapsi Kumar; Mark W Hurd; Matthew H G Katz; Ching-Wei D Tzeng; Shubham Pant; Milind Javle; David R Fogelman; Anirban Maitra; Cara L Haymaker
Journal:  Cancer Discov       Date:  2022-10-05       Impact factor: 38.272

7.  Neutrophils inhibit CD8+ T cells immune response by arginase-1 signaling in patients with sepsis.

Authors:  Xiao-Kang Dai; Zhen-Xing Ding; Yuan-Yuan Tan; Hua-Rui Bao; Dong-Yao Wang; Hong Zhang
Journal:  World J Emerg Med       Date:  2022

Review 8.  Novel targets for immunotherapy associated with exhausted CD8 + T cells in cancer.

Authors:  Lulu Zhang; Bo Zhang; Lin Li; Yingchun Ye; Yuchuan Wu; Qing Yuan; Wenfeng Xu; Xue Wen; Xiyuan Guo; Siji Nian
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-15       Impact factor: 4.322

9.  M2 macrophage-derived extracellular vesicles facilitate CD8+T cell exhaustion in hepatocellular carcinoma via the miR-21-5p/YOD1/YAP/β-catenin pathway.

Authors:  Jian Pu; Zuoming Xu; Jiahui Nian; Quan Fang; Meng Yang; Youguan Huang; Wenchuan Li; Bin Ge; Jianchu Wang; Huamei Wei
Journal:  Cell Death Discov       Date:  2021-07-16

10.  TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.

Authors:  Yuchuan Jiang; Siliang Chen; Qiang Li; Junjie Liang; Weida Lin; Jinying Li; Zhilong Liu; Mingbo Wen; Mingrong Cao; Jian Hong
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.